Limes Schlosskliniken AG

Limes Schlosskliniken AG

530.00
EUR
0.00
(0.00%)
162.38MMarket Cap
May 17Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
23.54
26.75
27.91
37.57
79.93
98.25
126.79
127.75
167.8
- -
Basic EPS, GAAP
-4.51
-5.26
-2.81
-2.37
13.45
14.34
11.58
10.61
19.11
- -
Free Cash Flow per Basic Share
- -
- -
- -
-3.64
-5.46
22.82
-11.98
8.47
3.82
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
9.8
11.51
9.14
21.2
37.86
51.6
62.52
84.95
81.78
Tangible Book Value per Share
-22.68
-10.47
-5.5
-5.91
-11.95
8.86
16.53
32.66
60.7
60.09
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
7
7
8
11
23
29
37
37
50
- -
Operating Margin (%)
-10.95
-12.48
-6.59
-3.87
19.33
6.74
13.52
11.45
18.62
- -
Depreciation Expense
- -
1
1
1
1
3
3
3
3
- -
Net Income, GAAP
-1
-1
-1
-1
4
4
3
3
6
- -
Effective Tax Rate (%)
- -
- -
- -
- -
4.57
13.25
14.75
21.97
22.44
- -
Profit Margin (%)
-19.17
-19.67
-10.08
-6.3
16.83
14.59
9.14
8.31
11.39
- -
Working Capital
-1
2
2
3
4
12
11
12
13
11
LT Debt
- -
6
- -
4
4
9
10
10
11
9
Total Equity
- -
3
3
3
6
11
17
20
27
26
Return on Invested Capital (%)
- -
- -
- -
- -
49.79
33.71
18.24
11.73
21.27
- -
Return on Capital (%)
- -
- -
- -
- -
44.02
22.95
12.28
10.49
12.82
- -
Return on Common Equity (%)
- -
-107.37
-27.07
-22.94
88.69
48.55
25.9
18.6
26.1
- -

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
12
11
9
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
114
104
162

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
21
20
19
Cash, Cash Equivalents & STI
11
10
8
Accounts Receivable, Net
7
9
10
Inventories
- -
- -
- -
Total Current Liabilities
6
7
8
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
63.2%
35.18%
Free Cash Flow
- -
-169.04%
-54.15%
Net Income, GAAP
- -
-121.2%
83.01%
Sales/Revenue/Turnover
- -
39.79%
33.49%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
37
2025
- -
- -
50
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
10.61
2025
- -
- -
19.11
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Gert Michael Frank
Full Time Employees
314
Sector
Health services
Industry
Medical/Nursing services
Address
Kaiser-Wilhelm-Ring 26 Cologne NW Germany 50672
IPO Date
Mar 18, 2019
Business
LIMES Schlosskliniken AG operates high-quality private clinics specializing in psychiatry, psychotherapy, and psychosomatics in Germany, Switzerland, and Liechtenstein. The company offers comprehensive treatment for stress-related illnesses and mental disorders, including depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorders, chronic pain, psychoses, obsessive-compulsive disorder, sleep disorders, somatoform disorders, and sports psychiatry; services encompass psychological assessments, psychiatric treatments, high-frequency psychotherapy, awareness and breathing exercises, meditation, yoga, personal training, acupuncture, ergotherapy, nutrition counseling, and innovative sports programs such as LIMES Sports.Care. Founded in 2005 and headquartered in Cologne, Germany, LIMES Schlosskliniken AG serves private patients, those entitled to subsidies, and self-payers through a network of exclusive facilities emphasizing relationship-oriented medicine and healing environments. As a subsidiary of GMF Capital GmbH, it provides centralized management, strategy, finances, branding, marketing, and acquisition services to its clinic operations. Recent expansions include the 2025 launches of LIMES Schlossklinik Bergisches Land in Lindlar, Germany, with 130 beds focused on mental health treatments like depression and anxiety, and LIMES Schlossklinik Abtsee in Berchtesgadener Land; earlier strategic moves encompass the 2023 acquisition of a 51% stake in Clinicum Alpinum AG in Liechtenstein and the 2021 purchase of 51% of Swiss PRC Group AG operating the Paracelsus Recovery Klinik in Zurich.